|
Title
|
|
|
|
Sclerosing bone dysplasias : leads toward novel osteoporosis treatments
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Sclerosing bone dysplasias are a group of rare, monogenic disorders characterized by increased bone density resulting from the disturbance in the fragile equilibrium between bone formation and resorption. Over the last decade, major contributions have been made toward better understanding of the pathogenesis of these conditions. These studies provided us with important insights into the bone biology and yielded the identification of numerous drug targets for the prevention and treatment of osteoporosis. Here, we review this heterogeneous group of disorders focusing on their utility in the development of novel osteoporosis therapies. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Current osteoporosis reports. - Philadelphia, Pa, 2003, currens
|
|
|
Publication
|
|
|
|
Philadelphia, Pa
:
2014
|
|
|
ISSN
|
|
|
|
1544-1873
|
|
|
DOI
|
|
|
|
10.1007/S11914-014-0220-5
|
|
|
Volume/pages
|
|
|
|
12
:3
(2014)
, p. 243-251
|
|
|
ISI
|
|
|
|
000347284200001
|
|
|
Pubmed ID
|
|
|
|
24947952
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|